Axon Enterprise Net Worth
Axon Enterprise Net Worth Breakdown | AXON |
Axon Enterprise Net Worth Analysis
Axon Enterprise's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Axon Enterprise's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Axon Enterprise's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Axon Enterprise's net worth analysis. One common approach is to calculate Axon Enterprise's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Axon Enterprise's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Axon Enterprise's net worth. This approach calculates the present value of Axon Enterprise's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Axon Enterprise's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Axon Enterprise's net worth. This involves comparing Axon Enterprise's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Axon Enterprise's net worth relative to its peers.
Enterprise Value |
|
To determine if Axon Enterprise is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Axon Enterprise's net worth research are outlined below:
Axon Enterprise appears to be risky and price may revert if volatility continues | |
Over 81.0% of the company shares are held by institutions such as insurance companies | |
Latest headline from investors.com: Disposition of tradable shares by Mcbrady Matthew R of Axon Enterprise at 611.0 subject to Rule 16b-3 |
Axon Enterprise uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Axon Enterprise. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Axon Enterprise's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
27th of February 2024 Upcoming Quarterly Report | View | |
14th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
27th of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
Know Axon Enterprise's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Axon Enterprise is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Axon Enterprise backward and forwards among themselves. Axon Enterprise's institutional investor refers to the entity that pools money to purchase Axon Enterprise's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Westfield Capital Management Company, Lp | 2024-09-30 | 1.2 M | Capital World Investors | 2024-09-30 | 974 K | Norges Bank | 2024-06-30 | 813.5 K | Broadwood Capital Inc | 2024-09-30 | 760.1 K | Champlain Investment Partners, Llc | 2024-09-30 | 682.4 K | Bank Of New York Mellon Corp | 2024-06-30 | 650.6 K | Northern Trust Corp | 2024-09-30 | 598.5 K | Ubs Asset Mgmt Americas Inc | 2024-09-30 | 561.3 K | Nuveen Asset Management, Llc | 2024-06-30 | 507.3 K | Blackrock Inc | 2024-06-30 | 8.3 M | Vanguard Group Inc | 2024-09-30 | 8.2 M |
Follow Axon Enterprise's market capitalization trends
The company currently falls under 'Large-Cap' category with a current market capitalization of 46.5 B.Market Cap |
|
Project Axon Enterprise's profitablity
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.05 | 0.05 | |
Return On Capital Employed | 0.06 | 0.09 | |
Return On Assets | 0.05 | 0.05 | |
Return On Equity | 0.11 | 0.07 |
When accessing Axon Enterprise's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Axon Enterprise's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Axon Enterprise's profitability and make more informed investment decisions.
Evaluate Axon Enterprise's management efficiency
Axon Enterprise has return on total asset (ROA) of 0.0229 % which means that it generated a profit of $0.0229 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1642 %, meaning that it created $0.1642 on every $100 dollars invested by stockholders. Axon Enterprise's management efficiency ratios could be used to measure how well Axon Enterprise manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Axon Enterprise's Return On Tangible Assets are very stable compared to the past year. As of the 22nd of November 2024, Return On Capital Employed is likely to grow to 0.09, while Return On Equity is likely to drop 0.07. At this time, Axon Enterprise's Net Tangible Assets are very stable compared to the past year. As of the 22nd of November 2024, Return On Tangible Assets is likely to grow to 0.05, while Other Assets are likely to drop 0.95.Last Reported | Projected for Next Year | ||
Book Value Per Share | 21.73 | 22.81 | |
Tangible Book Value Per Share | 20.68 | 21.72 | |
Enterprise Value Over EBITDA | 101.61 | 106.69 | |
Price Book Value Ratio | 11.89 | 12.48 | |
Enterprise Value Multiple | 101.61 | 106.69 | |
Price Fair Value | 11.89 | 12.48 | |
Enterprise Value | 400.7 M | 326.1 M |
The management team at Axon Enterprise has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Enterprise Value Revenue 23.7389 | Revenue 1.9 B | Quarterly Revenue Growth 0.317 | Revenue Per Share 25.727 | Return On Equity 0.1642 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Axon Enterprise insiders, such as employees or executives, is commonly permitted as long as it does not rely on Axon Enterprise's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Axon Enterprise insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Axon Enterprise Corporate Filings
F4 | 20th of November 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
10Q | 8th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
8K | 7th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
Axon Enterprise Earnings per Share Projection vs Actual
Axon Enterprise Corporate Management
Jeffrey Kunins | Chief Software | Profile | |
Jenner Holden | Chief Officer | Profile | |
Andrea James | Chief Officer | Profile | |
Ruth Sleeter | Chief Officer | Profile | |
Isaiah Fields | Corporate Officer | Profile | |
Erik Lapinski | Senior Relations | Profile |
Already Invested in Axon Enterprise?
The danger of trading Axon Enterprise is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Axon Enterprise is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Axon Enterprise. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Axon Enterprise is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Axon Enterprise offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axon Enterprise's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axon Enterprise Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axon Enterprise Stock: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axon Enterprise. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. To learn how to invest in Axon Stock, please use our How to Invest in Axon Enterprise guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Is Aerospace & Defense space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axon Enterprise. If investors know Axon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axon Enterprise listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.062 | Earnings Share 3.84 | Revenue Per Share 25.727 | Quarterly Revenue Growth 0.317 | Return On Assets 0.0229 |
The market value of Axon Enterprise is measured differently than its book value, which is the value of Axon that is recorded on the company's balance sheet. Investors also form their own opinion of Axon Enterprise's value that differs from its market value or its book value, called intrinsic value, which is Axon Enterprise's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axon Enterprise's market value can be influenced by many factors that don't directly affect Axon Enterprise's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Axon Enterprise's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axon Enterprise is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axon Enterprise's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.